Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Shepherd

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2014
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphomaA S Gerrie, M M Power, J D Shepherd, et al.
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1992
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMTT J Nevill, J D Shepherd, D E Reece, et al.
Leukemia & Lymphoma|February 1, 1993
Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposideJ D Shepherd, D E Reece, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1992
Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapyR J Cuthbert, G L Phillips, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1988
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host diseaseJ D Shepherd, T B Shore, D E Reece, et al.
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2014
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphomaA S Gerrie, M M Power, J D Shepherd, et al.
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1992
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMTT J Nevill, J D Shepherd, D E Reece, et al.
Leukemia & Lymphoma|February 1, 1993
Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposideJ D Shepherd, D E Reece, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1992
Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapyR J Cuthbert, G L Phillips, M J Barnett, et al.
Bone Marrow Transplantation|November 1, 1988
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host diseaseJ D Shepherd, T B Shore, D E Reece, et al.
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Pageof 8